MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,400 | +6300.0% | 17,777 | -91.6% | 0.00% | – |
| Q1 2023 | $100 | -16.7% | 211,927 | -11.5% | 0.00% | – |
| Q4 2022 | $120 | -99.6% | 239,401 | +714.0% | 0.00% | – |
| Q1 2021 | $31,000 | -94.8% | 29,409 | -93.3% | 0.00% | – |
| Q4 2020 | $597,000 | +1513.5% | 438,932 | +803.0% | 0.00% | – |
| Q3 2020 | $37,000 | -88.0% | 48,608 | -87.8% | 0.00% | – |
| Q2 2020 | $309,000 | -46.3% | 399,770 | -58.3% | 0.00% | -100.0% |
| Q1 2020 | $575,000 | +168.7% | 958,507 | +916.6% | 0.00% | – |
| Q4 2019 | $214,000 | -12.3% | 94,282 | -75.7% | 0.00% | – |
| Q3 2019 | $244,000 | -50.1% | 388,530 | -32.0% | 0.00% | -100.0% |
| Q2 2019 | $489,000 | -53.7% | 571,323 | -41.0% | 0.00% | -50.0% |
| Q1 2019 | $1,056,000 | +1430.4% | 968,908 | +1195.1% | 0.00% | – |
| Q3 2018 | $69,000 | -28.9% | 74,816 | -66.5% | 0.00% | – |
| Q2 2018 | $97,000 | +12.8% | 223,298 | +339.9% | 0.00% | – |
| Q2 2017 | $86,000 | -89.9% | 50,766 | -83.5% | 0.00% | -100.0% |
| Q1 2017 | $854,000 | – | 308,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
| Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
| CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
| Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
| Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
| Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
| J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
| Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
| IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |